ISOMETHEPTENE‐A NON‐ERGOT DRUG IN THE TREATMENT OF MIGRAINE
@article{Diamond1975ISOMETHEPTENEAND,
title={ISOMETHEPTENE‐A NON‐ERGOT DRUG IN THE TREATMENT OF MIGRAINE},
author={Sharon Diamond and Jos{\'e} Lu{\'i}s Medina},
journal={Headache: The Journal of Head and Face Pain},
year={1975},
volume={15}
}SYNOPSIS
21 Citations
Effect of Isometheptene on the Distribution and Shunting of 15μ M Microspheres Throughout the Cephalic Circulation of the Cat
- GeologyHeadache
- 1980
SYNOPSIS
Comparative Study of a Combination of Isometheptene Mucate, Dichloralphenazone With Acetaminophen and Sumatriptan Succinate in the Treatment of Migraine
- MedicineHeadache
- 2001
Objective.—To compare the safety and efficacy of isometheptene mucate, dichloralphenazone with acetaminophen to sumatriptan succinate for the treatment of mild‐to‐moderate migraine, with or without…
The pharmacological management of migraine, part 1: overview and abortive therapy.
- Medicine, PsychologyP & T : a peer-reviewed journal for formulary management
- 2008
Part 1 of a two-part series presents a summary of treatments used to reduce the severity and duration of migraine and its associated symptoms and also discusses the comorbidities, clinical presentation, and risk factors associated with this affliction.
Pharmacological Management of Migraine
- Medicine
- 2017
This chapter will cover typical medications used and the development of pharmacological plans for use during the acute migraine attack and longer term migraine management, as well as briefly covering Emergency Department management and inpatient management of migraine.
Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors
- MedicinePain
- 2005
Fixed Drug Combinations for the Acute Treatment of Migraine
- Medicine, PsychologyCNS drugs
- 2005
With renewed interest in the use of FDCs for the acute treatment of migraine, high-quality evidence of a benefit for such treatments is emerging, and the most consistent and impressive evidence of benefit is for NSAID-containing F DCs.
Practical Approaches to Migraine Management
- Medicine
- 2002
Preventative medication therapy is indicated for patients experiencing frequent and/or refractory attacks and recently published evidence-based guidelines advocate migraine-specific drugs, such as serotonin 5-HT1b/1d agonists and dihydroergotamine mesylate, for patients experience moderate to severe migraine attacks.
The severity model of chronic headache
- Medicine, PsychologyJournal of General Internal Medicine
- 2007
Primary care physicians have abundant opportunities to amplify research on the psychosomatic sources of headache, develop and refine the utility of the severity model, and elucidate the role of the physician — patient relationship as a specific form of treatment.
References
SHOWING 1-7 OF 7 REFERENCES
CONTROLLED STUDIES OF A NEW AGENT IN VASCULAR HEADACHE
- Medicine, PsychologyHeadache
- 1963
It is shown that pain in the frontal area is the most common type involved in chronic vascular headaches, and the syndrome is named "Frontal Headache.
Recent advances in treatment of migraine.
- Medicine, PsychologyJournal of the American Medical Association
- 1951
Treatment of migraine has posed a problem for many years and the number and multiplicity of therapeutic agents and the uniformly good results reported with these medicaments indicate the unsatisfactory state of knowledge concerning treatment.
Headache Clinics IV: The Use of Octin in the Treatment of Headache
- Am. Pract. 4:31-34,
- 1953
Studies in the Pharmacology of Headache
- Neurology
- 1963
Ad Hoc Committee on Classification of Headache, National Institute of Neurological Diseases and Blindness, National institute of Health
- JAMA
- 1962
eds).: The Pharmacological Basis of Therapeutics, ed
- 1970